Literature DB >> 25351971

Price elasticity and medication use: cost sharing across multiple clinical conditions.

Justin Gatwood1, Teresa B Gibson, Michael E Chernew, Amanda M Farr, Emily Vogtmann, A Mark Fendrick.   

Abstract

BACKGROUND: To address the impact that out-of-pocket prices may have on medication use, it is vital to understand how the demand for medications may be affected when patients are faced with changes in the price to acquire treatment and how price responsiveness differs across medication classes.
OBJECTIVE: To examine the impact of cost-sharing changes on the demand for 8 classes of prescription medications.
METHODS: This was a retrospective database analysis of 11,550,363 commercially insured enrollees within the 2005-2009 MarketScan Database. Patient cost sharing, expressed as a price index for each medication class, was the main explanatory variable to examine the price elasticity of demand. Negative binomial fixed effect models were estimated to examine medication fills. The elasticity estimates reflect how use changes over time as a function of changes in copayments.
RESULTS: Model estimates revealed that price elasticity of demand ranged from -0.015 to -0.157 within the 8 categories of medications (P  less than  0.01 for 7 of 8 categories). The price elasticity of demand for smoking deterrents was largest (-0.157, P  less than  0.0001), while demand for antiplatelet agents was not responsive to price (P  greater than 0.05).
CONCLUSIONS: The price elasticity of demand varied considerably by medication class, suggesting that the influence of cost sharing on medication use may be related to characteristics inherent to each medication class or underlying condition.

Entities:  

Mesh:

Year:  2014        PMID: 25351971     DOI: 10.18553/jmcp.2014.20.11.1102

Source DB:  PubMed          Journal:  J Manag Care Spec Pharm


  6 in total

1.  Effect of Out-of-Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE).

Authors:  Andrew J Karter; Melissa M Parker; Matthew D Solomon; Courtney R Lyles; Alyce S Adams; Howard H Moffet; Mary E Reed
Journal:  Health Serv Res       Date:  2017-05-05       Impact factor: 3.402

2.  Comparing Gold-standard Copayment and Coinsurance Values From Claims Processing Engines to Values Derived From Behavioral Health Claims Databases.

Authors:  Sarah A Friedman; Haiyong Xu; Francisca Azocar; Susan L Ettner
Journal:  Med Care       Date:  2022-04-01       Impact factor: 2.983

3.  Cost-Sharing Rates Increase During Deep Recession: Preliminary Data From Greece.

Authors:  Athanasios Gouvalas; Michael Igoumenidis; Mamas Theodorou; Kostas Athanasakis
Journal:  Int J Health Policy Manag       Date:  2016-05-28

4.  Will converting naloxone to over-the-counter status increase pharmacy sales?

Authors:  Sean M Murphy; Jake R Morgan; Philip J Jeng; Bruce R Schackman
Journal:  Health Serv Res       Date:  2019-02-20       Impact factor: 3.402

5.  Do out-of-pocket costs influence retention and adherence to medications for opioid use disorder?

Authors:  Christopher Dunphy; Cora Peterson; Kun Zhang; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2021-05-21       Impact factor: 4.852

6.  Assessing out-of-pocket expenditures for primary health care: how responsive is the Democratic Republic of Congo health system to providing financial risk protection?

Authors:  Samia Laokri; Rieza Soelaeman; David R Hotchkiss
Journal:  BMC Health Serv Res       Date:  2018-06-15       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.